ZNRF3 and neoplasm: However, canonical WNT signaling, based on levels of active-β-Catenin (non-phosphorylated at Ser33/37/Thr41; Fig. 7B), remained unaffected, suggesting that ZNRF3 suppresses tumor growth through down-regulation of EGRF signaling without substantial involvement of canonical WNT signaling.